GlassScriptPhysician profile
Michael Lane
NPI 1457932337
$4,243.47
in general payments reported to CMS, 2019-2025
14 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $781 · 2023: $791 · 2024: $2,328 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,800 · Food and Beverage: $1,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,800.00 |
| Food and Beverage | $1,662.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $1,987.73 | 2023-2025 | Loreev Xr |
| Abbvie INC. | $695.23 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $469.78 | 2022-2025 | Spravato |
| Alkermes, INC. | $284.91 | 2022-2023 | Aristada, Aristada Initio, Vivitrol |
| Otsuka America Pharmaceutical, INC. | $268.89 | 2022-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Idorsia Pharmaceuticals US INC | $123.42 | 2022-2024 | Quviviq |
| Axsome Therapeutics, INC. | $117.11 | 2024 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $65.42 | 2022 | |
| Indivior INC. | $52.03 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $47.14 | 2022 | |
| Medtronic, INC. | $45.47 | 2024-2025 | Intellis Adaptivestim, Corevalve Evolut R |
| Owp Pharmaceuticals, INC. | $39.31 | 2022 | |
| Tris Pharma INC | $27.34 | 2022 | |
| Brainsway USA INC | $19.69 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.